BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 29103691)

  • 1. Immunogenicity and protective efficacy of inactivated equine influenza (H3N8) virus vaccine in murine model.
    Pavulraj S; Virmani N; Bera BC; Joshi A; Anand T; Virmani M; Singh R; Singh RK; Tripathi BN
    Vet Microbiol; 2017 Oct; 210():188-196. PubMed ID: 29103691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological and immunological protection induced by inactivated reverse genetics-based H3N8 equine influenza vaccine candidate in murine model.
    Kumar R; Gupta RP; Bera BC; Anand T; Bhatia S; Kumar N; Sood R; Pavulraj S; Mathew MK; Balena V; Karthik S; Sansanwal R; Tripathi BN; Virmani N
    Acta Virol; 2020; 64(3):359-374. PubMed ID: 32985215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
    Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H
    Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of immunogenicity and protective efficacy of bacteriophage conjugated haemagglutinin based subunit vaccine against equine influenza virus in a murine model.
    Kumar R; Bera BC; Anand T; Pavulraj S; Kurian Mathew M; Gupta RP; Tripathi BN; Virmani N
    Vet Res Commun; 2024 Jun; 48(3):1707-1726. PubMed ID: 38528300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.
    Paillot R; Prowse L; Montesso F; Huang CM; Barnes H; Escala J
    Vet Microbiol; 2013 Mar; 162(2-4):396-407. PubMed ID: 23146168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of Equine Influenza virus (H3N8) in Murine Model.
    Pavulraj S; Bera BC; Joshi A; Anand T; Virmani M; Vaid RK; Shanmugasundaram K; Gulati BR; Rajukumar K; Singh R; Misri J; Singh RK; Tripathi BN; Virmani N
    PLoS One; 2015; 10(11):e0143094. PubMed ID: 26587990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
    Lopez AM; Hecker R; Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA; Townsend HG
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):103-10. PubMed ID: 16950519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective efficacy of inactivated reverse genetics based equine influenza vaccine candidate adjuvanted with Montanide
    Mathew MK; Virmani N; Bera BC; Anand T; Kumar R; Balena V; Sansanwal R; Pavulraj S; Sundaram K; Virmani M; Tripathi BN
    J Vet Med Sci; 2019 Dec; 81(12):1753-1762. PubMed ID: 31656240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of a novel cold-adapted modified-live equine influenza virus vaccine.
    Tabynov K; Kydyrbayev Z; Ryskeldinova S; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
    Aust Vet J; 2014 Nov; 92(11):450-7. PubMed ID: 25348146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets.
    Baz M; Paskel M; Matsuoka Y; Zengel J; Cheng X; Treanor JJ; Jin H; Subbarao K
    J Virol; 2015 Feb; 89(3):1652-9. PubMed ID: 25410860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination.
    Soboll G; Hussey SB; Minke JM; Landolt GA; Hunter JS; Jagannatha S; Lunn DP
    Vet Immunol Immunopathol; 2010 May; 135(1-2):100-107. PubMed ID: 20018384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update of inactivated equine influenza vaccine strain in Japan.
    Gamoh K; Nakamura S
    J Vet Med Sci; 2017 Mar; 79(3):649-653. PubMed ID: 28163276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach.
    Gildea S; Sanchez Higgins MJ; Johnson G; Walsh C; Cullinane A
    Influenza Other Respir Viruses; 2016 Sep; 10(5):433-7. PubMed ID: 27169603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of equine influenza vaccines for protection against A/Equine/Jilin/89 (H3N8)--a new equine influenza virus.
    Webster RG; Thomas TL
    Vaccine; 1993; 11(10):987-93. PubMed ID: 8212831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA).
    Galvin P; Gildea S; Arkins S; Walsh C; Cullinane A
    Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):73-80. PubMed ID: 24224822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
    Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N
    Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel equine influenza virus live-attenuated vaccine.
    Rodriguez L; Reedy S; Nogales A; Murcia PR; Chambers TM; Martinez-Sobrido L
    Virology; 2018 Mar; 516():76-85. PubMed ID: 29331866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
    Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.